Next-generation sequencing of FLT3 internal tandem duplications for minimal residual disease monitoring in acute myeloid leukemia.
about
Minimal Residual Disease in Acute Myeloid Leukemia of Adults: Determination, Prognostic Impact and Clinical ApplicationsA Novel Tandem Duplication Assay to Detect Minimal Residual Disease in FLT3/ITD AML.High frequency of additional gene mutations in acute myeloid leukemia with MLL partial tandem duplication: DNMT3A mutation is associated with poor prognosis.FLT3 inhibitors: clinical potential in acute myeloid leukemia.Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia.Precision and prognostic value of clone-specific minimal residual disease in acute myeloid leukemia.Enhancing acute myeloid leukemia therapy - monitoring response using residual disease testing as a guide to therapeutic decision-making.Relapse risk and survival in patients with FLT3 mutated acute myeloid leukemia undergoing stem cell transplantation.Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing.Emerging molecular predictive and prognostic factors in acute myeloid leukemia.Methods of Detection of Measurable Residual Disease in AML.An update on PCR use for minimal residual disease monitoring in acute lymphoblastic leukemia.New chimeric RNAs in acute myeloid leukemia.Clonal heterogeneity of -ITD detected by high-throughput amplicon sequencing correlates with adverse prognosis in acute myeloid leukemia
P2860
Q28073464-C054F873-2628-4CBA-A7AA-53A587D76373Q36304815-824615BC-1EB9-4959-BE0B-0A0DDFEC6ACDQ36545112-9BA3A97A-A21B-4E94-B61F-9D63F138E297Q37638749-DF613266-5A4F-4D56-BD90-9F5D52F9D819Q38755213-7572A4E6-84AC-4D1E-A432-00A85AADD002Q38902497-2F6DE7E9-AEEB-4E04-A411-8148F114DBDEQ39285841-AF1CBA74-79FB-4A0F-8F6E-7B4DFA17BDF4Q40396505-43C2D13B-CE7C-4CFC-AC6A-2B3ED00AC8B9Q42322251-CE321208-368D-4341-B9A5-56C535814D4AQ47670541-669F68AC-BF45-4ACD-8BED-6B236C8D172DQ47862030-31B5A5F6-3FF6-46B1-96A3-B022D72480BCQ47955491-4A42095E-9BAB-4609-944E-6833B0CA1F94Q52328823-A70C4E97-118C-4E0B-B80A-EC8637B3D5A3Q56968572-F1873D05-BF2E-441C-A409-06EA14633463
P2860
Next-generation sequencing of FLT3 internal tandem duplications for minimal residual disease monitoring in acute myeloid leukemia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Next-generation sequencing of ...... ing in acute myeloid leukemia.
@ast
Next-generation sequencing of ...... ing in acute myeloid leukemia.
@en
type
label
Next-generation sequencing of ...... ing in acute myeloid leukemia.
@ast
Next-generation sequencing of ...... ing in acute myeloid leukemia.
@en
prefLabel
Next-generation sequencing of ...... ing in acute myeloid leukemia.
@ast
Next-generation sequencing of ...... ing in acute myeloid leukemia.
@en
P2093
P2860
P50
P356
P1433
P1476
Next-generation sequencing of ...... ing in acute myeloid leukemia.
@en
P2093
Aline Renneville
Bérengère Gruson
Céline Rodriguez
Nathalie Hélevaut
Philippe Rousselot
Sabine Quief
Shéhérazade Sebda
Sylvie Castaigne
P2860
P304
22812-22821
P356
10.18632/ONCOTARGET.4333
P407
P577
2015-06-02T00:00:00Z